Benzinga | Oct 28, 2020 11:26AM EDT

Canaccord Genuity Maintains Buy on Exact Sciences, Raises Price Target to $145

Canaccord Genuity analyst Max Masucci maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $120 to $145.